Biblio

Found 18 results
Filters: Keyword is Principal Component Analysis  [Clear All Filters]
2011
Teichert F, Winkler S, Keun HC, Steward WP, Gescher AJ, Farmer PB, Singh R.  2011.  Evaluation of urinary ribonucleoside profiling for clinical biomarker discovery using constant neutral loss scanning liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 25(14):2071-82.
Kinross JM, Alkhamesi N, Barton RH, Silk DB, Yap IKS, Darzi AW, Holmes E, Nicholson JK.  2011.  Global metabolic phenotyping in an experimental laparotomy model of surgical trauma.. J Proteome Res. 10(1):277-87.
Spagou K, Wilson ID, Masson P, Theodoridis G, Raikos N, Coen M, Holmes E, Lindon JC, Plumb RS, Nicholson JK et al..  2011.  HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies.. Anal Chem. 83(1):382-90.
Edmands WMB, Beckonert OP, Stella C, Campbell A, Lake BG, Lindon JC, Holmes E, Gooderham NJ.  2011.  Identification of human urinary biomarkers of cruciferous vegetable consumption by metabonomic profiling.. J Proteome Res. 10(10):4513-21.
Ellis J K, Athersuch T J, Cavill R, Radford R, Slattery C, Jennings P, McMorrow T, Ryan MP, Ebbels T M D, Keun H C.  2011.  Metabolic response to low-level toxicant exposure in a novel renal tubule epithelial cell system.. Mol Biosyst. 7(1):247-57.
Veselkov KA, Vingara LK, Masson P, Robinette SL, Want E, Li JV, Barton RH, Boursier-Neyret C, Walther B, Ebbels TM et al..  2011.  Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery.. Anal Chem. 83(15):5864-72.
Nicholson JK, Wilson ID, Lindon JC.  2011.  Pharmacometabonomics as an effector for personalized medicine.. Pharmacogenomics. 12(1):103-11.
Ebbels TMD, Lindon JC, Coen M.  2011.  Processing and modeling of nuclear magnetic resonance (NMR) metabolic profiles.. Methods Mol Biol. 708:365-88.